Wild-type IDH1 inhibition enhances chemotherapy response in melanoma
Mehrdad Zarei(University Hospitals of Cleveland), Luke D. Rothermel(University Hospitals of Cleveland)
Cited by 19
Related Papers
IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer
|Cancer Research|2024|22
Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and Chemoresistance in Pancreatic Ductal Adenocarcinoma
|Cancer Research Communications|2021|18